Chrono-Log

Chrono-Log

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Chrono-Log is a specialized diagnostics company with over 50 years of experience in hematology, specifically platelet function testing. Its core business revolves around manufacturing platelet aggregometers and associated reagents, serving both clinical labs for patient management and research institutions for drug development. The company has a stable portfolio of FDA-cleared products and maintains an international sales presence through representatives in Europe. It operates as a mature, niche player in the global hemostasis diagnostics market.

HematologyCardiovascular

Technology Platform

Proprietary platelet aggregation and secretion measurement technologies, including Optical/Light Transmission Aggregation (LTA), Whole Blood/Impedance Aggregation, and simultaneous Lumi-Aggregation (aggregation + ATP release). Supported by dedicated reagents, controls, and analysis software.

Opportunities

Growing use of anti-platelet drugs and personalized medicine drives demand for platelet function monitoring.
Expansion of diagnostic applications for existing technology, such as in COVID-19 research, opens new market segments.
Recurring revenue from consumables for a large, established installed base provides stable cash flow.

Risk Factors

Heavy reliance on a niche technology (platelet aggregometry) within the larger, competitive IVD market.
Potential for technological disruption from automated, high-throughput, or point-of-care systems from larger competitors.
Clinical demand and reimbursement can be influenced by shifting medical guidelines for platelet function testing.

Competitive Landscape

Chrono-Log competes in the platelet function testing segment against larger diversified diagnostics companies (e.g., Siemens Healthineers, Roche, Werfen/Instrumentation Laboratory) that offer automated coagulation analyzers with platelet function modules, as well as other specialized aggregometer manufacturers (e.g., Bio/Data Corporation). Its competitive edge is deep specialization, a comprehensive product portfolio for platelet testing, and a reputation as a gold-standard tool in research.